摘要
小细胞肺癌(SCLC)是最常见的肺部原发的神经内分泌肿瘤,生长速度快,易早期转移,预后差。CT作为SCLC最常用的影像检查方法,熟悉其常见CT表现非常重要;MRI可更好地显示SCLC的颅脑转移灶,MR扩散加权成像在诊断与鉴别诊断SCLC时可提供分子水平的信息;PET/CT在SCLC的临床分期上较CT更准确,可更好地评估治疗效果和预后。SCLC的治疗主要是采取放疗和化疗,对没有淋巴结转移的Ⅰ期(T_(1-2),N0)SCLC病人行手术治疗,可以提高病人生存率。就SCLC影像表现及治疗进展进行综述。
Small cell lung cancer（SCLC） is the most common primary neuroendocrine malignancy of the lung and is characterized by a rapid doubling time, easy metastasis in early stage and poor prognosis. CT is the most commonly examination method. Familiar with the CT features of SCLC is essential. MRI can better show the brain metastasis of SCLC.DWI can provide molecular level information in the diagnosis and differential diagnosis of SCLC. PET/CT is more accurate than CT in the clinical staging of SCLC, and it is better to evaluate the therapeutic effect and prognosis. The main treatment of SCLC is radiotherapy and chemotherapy. Surgery should be considered in patients with stage Ⅰ（T1-2, N0）, can improve the survival rate of patients. In this paper we reviewed imaging findings and progress in treatment of SCLC.
出处
《国际医学放射学杂志》
2017年第2期152-156,共5页
International Journal of Medical Radiology
基金
国家自然科学基金面上项目(81271572)
国家自然科学青年基金(81301252)
上海市市级医院适宜技术项目(SHDC12014227)
总后勤部卫生部保健专项科研课题(14BJZ50)
